WATCH: Is Bayer losing the Roundup fight?
The New Lede breaks down the latest developments in the courtroom and corporate boardroom and asks the question: is Bayer ready to throw in the towel on Roundup?
The New Lede breaks down the latest developments in the courtroom and corporate boardroom and asks the question: is Bayer ready to throw in the towel on Roundup?
By Carey Gillam
Bayer this week put a halt to its latest courtroom battle over allegations that its weed killing products cause cancer, settling a Missouri case after four weeks of testimony and just as the trial was coming to a close.
Bayer executives have been warning in recent weeks that after losing billions of dollars to Roundup case settlements and jury awards, they may be ready to give up the fight.
By Carey Gillam
A Georgia jury verdict ordering Bayer AG to pay over $2 billion to a man suffering from cancer he blamed on his use of Roundup weed killer comes as that state’s governor weighs whether to sign into law a measure that would effectively bar such cases from going to trial in the future.
By Carey Gillam
An Oregon appeals court on Wednesday overturned a trial victory by Monsanto owner Bayer AG in a decision that adds to an ongoing debate over the company’s efforts to create a nationwide legal and legislative shield from lawsuits alleging Roundup weed killer causes cancer.
Faced with a startlingly high cancer rate in the key US farm state of Iowa, public health leaders are taking the politically precarious step of acknowledging that preventing disease necessitates cutting exposure to potentially cancer-causing chemicals, including those used in agriculture.
By Carey Gillam
Citing new scientific research, a coalition of farmworker, public health and environmental advocates on Wednesday filed a legal petition with US regulators demanding they immediately suspend authorization for the controversial weed killing chemical called glyphosate.
By Carey Gillam
Cancer patients are celebrating a string of courtroom victories after juries in three US states recently ordered Germany’s Bayer to pay more than $500 million in damages for failing to warn about the health risks of its Roundup herbicides. But the consumer wins come as proposed federal legislation backed by Bayer and the powerful agricultural industry could limit similar cases from ever going to trial in the future.
By Carey Gillam
Lawyers representing a man who blames his cancer on exposure to Monsanto’s Roundup weed killer are crying foul over what they say are close personal ties between a lead Monsanto lawyer and a special magistrate helping oversee the Roundup litigation.
A federal judge has given the green light for a class-action lawsuit to proceed against Bayer AG brought by investors unhappy with the company’s $63 billion purchase of Monsanto Co. in 2018.